Mohamed Altai
Lund, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
Corrigendum to "Impact of site-specific conjugation strategies on the pharmacokinetics of antibody-conjugated radiotherapeutics" [Eur J Med Chem. 2024 Dec 15; 280:116927. doi: 10.1016/j.ejmech.2024.116927. PMID: 39378827].
Journal: European journal of medicinal chemistry
Published: January 20, 2026
Key Regulatory Elements of the TGFβ-LRRC15 Axis Predict Disease Progression and Immunotherapy Resistance Across Cancer Types.
Journal: bioRxiv : the preprint server for biology
Published: December 09, 2024
Intratumoral Distribution of [177Lu]Lu-PSMA-617 Over Time and in Relation to Diagnostic Tracers in Animal Models of Prostate Cancer.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: November 28, 2024
Optimizing peptide nucleic acid-based pretargeting for enhanced targeted radionuclide therapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 27, 2024
Development of a leucine-rich repeat-containing protein 15-targeted radio-immunotheranostic approach to deplete pro-tumorigenic mechanisms and immunotherapy resistance.
Journal: Signal transduction and targeted therapy
Published: August 01, 2024
Impact of site-specific conjugation strategies on the pharmacokinetics of antibody conjugated radiotherapeutics.
Journal: European journal of medicinal chemistry
Published: July 09, 2024
Hematological and renal toxicity in mice after three cycles of high activity [177Lu]Lu-PSMA-617 with or without human α1-microglobulin.
Journal: Scientific reports
Published: December 05, 2023
Co-injection of anti-HER2 antibody Trastuzumab does not increase efficacy of [177Lu]Lu-PSMA-617 therapy in an animal model of prostate cancer.
Journal: American journal of nuclear medicine and molecular imaging
Published: March 15, 2023
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response.
Journal: Molecular cancer research : MCR
Published: September 16, 2022
Hematological Toxicity in Mice after High Activity Injections of 177Lu-PSMA-617.
Journal: Pharmaceutics
Published: February 22, 2022
The Influence of Domain Permutations of an Albumin-Binding Domain-Fused HER2-Targeting Affibody-Based Drug Conjugate on Tumor Cell Proliferation and Therapy Efficacy.
Journal: Pharmaceutics
Published: September 30, 2021
Last Updated: 09/26/2026